Loading resource…

Obstetrics and Gynecology
The FIGO 2023 dosing chart outlines the recommended dosages and administration routes for Mifepristone and Misoprostol across different gestational ages and clinical scenarios. It includes specific regimens for induced abortion, missed abortion, incomplete abortion, and cervical preparation before aspiration. The chart also highlights important notes regarding the safety and administration of Misoprostol, particularly in relation to prior cesarean deliveries and the management of postpartum hemorrhage.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Rwanda Gynecology and Obstetrics Clinical Protocols and Treatment Guidelines
Same clinical topic · Obstetrics and Gynecology

Essential Maternal and Newborn Clinical Care Guidelines for Uganda
Same clinical topic · Obstetrics and Gynecology

Postabortion Care Guidelines
Same clinical topic · Obstetrics and Gynecology

Obstetric Fistula: Guiding Principles for Clinical Management
Same clinical topic · Obstetrics and Gynecology

Clinical Management of Obstetric and Neonatal Emergencies in Africa
Same clinical topic · Obstetrics and Gynecology

SOCIETY FOR MATERNAL-FETAL MEDICINE SPECIAL STATEMENT: REDUCING THE RISK OF TRANSMITTING INFECTION DURING ULTRASOUND EXAMINATION—UPDATED 2026
Same clinical topic · Obstetrics and Gynecology

WHO/FIGO/ICM NEW RECOMMENDATIONS FOR PPH PREVENTION AND MANAGEMENT
Same clinical topic · Obstetrics and Gynecology

Maternal and Perinatal Death Surveillance and Response Guidelines
Same clinical topic · Obstetrics and Gynecology

A POCKET GUIDE FOR CLINICAL MANAGEMENT OF OBSTETRIC AND NEONATAL EMERGENCIES IN AFRICA
Same clinical topic · Obstetrics and Gynecology